| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 15 |
| 1 | INFLIXIMAB | 9 |
| 2 | ATAZANAVIR | 6 |
| 3 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 5 |
| 4 | INTERFERON BETA-1A | 5 |
| 5 | PIRTOBRUTINIB | 5 |
| 6 | RITONAVIR | 5 |
| 7 | RITUXIMAB | 5 |
| 8 | VENETOCLAX | 5 |
| 9 | ADALIMUMAB-AATY | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PIRTOBRUTINIB | 5 | 0.0051 |
| 1 | CASPOFUNGIN ACETATE | 1 | 0.0006 |
| 2 | FOLLITROPIN ALFA | 1 | 0.0005 |
| 3 | MARAVIROC | 1 | 0.0004 |
| 4 | ATAZANAVIR | 6 | 0.0004 |
| 5 | RASBURICASE | 1 | 0.0004 |
| 6 | ZIDOVUDINE | 4 | 0.0004 |
| 7 | CHORIOGONADOTROPIN ALFA | 1 | 0.0004 |
| 8 | FAMOTITINE | 1 | 0.0003 |
| 9 | GOLIMUMAB | 4 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Gonadotropin [EPC] | 1 | 0.0005 |
| 1 | CCR5 Co-receptor Antagonist [EPC] | 1 | 0.0004 |
| 2 | Vitamin D2 Analog [EPC] | 1 | 0.0001 |
| 3 | Protease Inhibitor [EPC] | 6 | 0.0001 |
| 4 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 5 | Cytochrome P450 3A Inhibitor [EPC] | 6 | 0.0001 |
| 6 | BCL-2 Inhibitor [EPC] | 5 | 0.0001 |
| 7 | Androgen [EPC] | 2 | 0.0001 |
| 8 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |
| 9 | Interleukin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |